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Introduction
Human inflammatory bowel diseases (IBD) including
Crohn diseases and ulcerative colitis are chronic
immune-mediated disorders whose pathogenesis and
etiology are largely unknown (1). A number of gene-
manipulated murine models of colitis have been devel-
oped. These include IL-10–deficient, T cell receptor-
α–deficient, Gαi2–deficient, Stat4-transgenic, and
T-bet-transgenic mice (2–5). Experimentally induced
models of colitis have also been established by recon-
stituting immunocompromised mice with CD4+
CD45RBhigh T cells. All of these models are used in
attempts to elucidate the pathogenesis of IBD. As a
result, it has been proposed that an exaggerated bias
toward Th1 or Th2 polarization in the mucosal immune
system is a key factor in the pathogenesis of colitis (6, 7).
In IL-10–deficient mice, CD4+ T cells residing in the
lamina propria region of intestinal tract preferentially
produced IFN-γ (8). Immunocompromised mice trans-
ferred with T cells from IL-10–deficient mice developed
colitis with skewed Th1 responses (9). Furthermore,
treatment with anti–IFN-γ Ab significantly delayed the
onset of the disease and reduced the severity of colitis in
young IL-10–deficient mice (8). Treatment of anti-IL-12
Ab prevented the development of the disease in young
IL-10–deficient, but not in aged IL-10–deficient, mice (7,
10). Thus, the involvement of Th1 cells has become clear
in the pathogenesis of early phase of colitis in IL-10–defi-
cient mice. IL-10 is a well-known regulatory cytokine,
which can provide positive and negative signals on a vari-
ety of immune cells including B cells, T cells, NK cells,
mast cells, and myeloid cells (11). Additionally, IL-10 has
recently been shown to play an important role in the dif-
ferentiation and function of regulatory T cells, which
possess a capacity to inhibit harmful immune disorders
including chronic colitis (12, 13). Although it is now
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clear that IL-10 plays an essential role in the negative reg-
ulation of inflammatory responses in the intestine, the
mechanism by which IL-10 exerts the anti-inflammato-
ry responses remains unclear.
The STAT family of transcription factors, consisting
of seven members, is involved in cytokine signaling.
The knockout of each member of the STAT family in
mice resulted in impaired responses to corresponding
cytokines, demonstrating that STAT proteins have
essential roles in cytokine-mediated biological respons-
es (14, 15). Unlike the knockout of all other STAT
family members, the knockout of Stat3 resulted in
early death in embryogenesis (16). Therefore, Stat3
has been deleted in a cell- or tissue-specific manner by
the Cre-loxP recombination system in order to exam-
ine biological and functional roles of the transcription
factor in vivo (17–19). For example, mice lacking Stat3
in myeloid cells such as macrophages, neutrophils,
and dendritic cells developed chronic enterocolitis
and showed exaggerated Th1 responses (20). The
immunological and histological analysis revealed very
similar disease development in the intestinal tract of
IL-10–deficient mice. Macrophages from the Stat3
mutant mice did not show any anti-inflammatory
responses mediated by IL-10 and produced increased
levels of inflammatory cytokines in response to bacte-
rial LPS, demonstrating that Stat3 is essential for the
IL-10–mediated signaling pathways in myeloid cells
(20). This study also indicated that myeloid cells,
including macrophages and dendritic cells, are major
targets for IL-10 exhibiting anti-inflammatory
responses in vivo, and the abnormal activation of
myeloid cells is involved in the pathogenesis of chron-
ic colitis in mice. It remains elusive, however, how the
abnormal activation of myeloid cells leads to the
development of colitis in vivo.
In this study, we examined the in vivo mechanism by
which activated myeloid cells in the absence of IL-10 sig-
naling induce chronic colitis using Stat3 mutant mice
with additional deleted alleles, such as Stat1, TNF-α, 
IL-12p40, RAG2, and Toll-like receptor 4 (TLR4).
Methods
Mice. Stat3 mutant (LysMcre; Stat3flox/flox) mice on a mixed
129 × C57BL/6 genetic background (backcrossed to
C57BL/6 for three generations) were used in this study
(17, 20). Stat1-deficient mice on a C57BL/6 background
were mated with Stat3 mutant mice (21). TNF-α–defi-
cient and IL-12p40–deficient mice on a C57BL/6 back-
ground were kindly provided by K. Sekikawa and J.
Magram, respectively (22, 23). RAG2-deficient mice on a
C57BL/6 background were kindly provided by Fred Alt
(Harvard Medical School and Center for Blood Research,
Boston, Massachusetts, USA). TLR4-deficient mice were
generated as described previously (24). Littermate wild-
type or heterozygous mutant mice were used for experi-
ments as control mice. All mice were housed in a specif-
ic pathogen-free facility at the Research Institute for
Microbial Diseases, Osaka University (Osaka, Japan).
Histopathological analysis. Paraffin-embedded colon
samples were sectioned and stained with H&E. Trans-
verse sections are shown in the figures. Severity of coli-
tis was evaluated by the standard scoring system as
described previously (25). Each region of the colon
(cecum; ascending, transverse, and descending colon;
and rectum) was graded semiquantitatively from 0 (no
change) to 5 (most severe change). The grading repre-
sents an increasing incidence and degree of inflamma-
tion, goblet cell loss, crypt abscesses and ulceration,
and fibrosis in the lamina propria. The summation of
the score for each segment of the colon provides a total
disease score per mouse (0–25) where: 0 indicates no
change; 1–5, mild disease; 6–10, mild-moderate; and
11–20, severe. No mice in these studies had a score
above 20 because such severe disease results in death.
The scoring was performed blinded manner by two
independent investigators. The colitis scores were eval-
uated using the program Statview II (SAS Inc., Cary,
North Carolina, USA). P values less than 0.05 were
assumed to be statistically significant.
Cytokine production by macrophages. Mice were intraperi-
toneally injected with 2 ml of 4% thioglycollate medium
(Sigma-Aldrich, St. Louis, Missouri, USA). Three days
later, peritoneal exudate cells were isolated from the
peritoneal cavity by washing with ice-cold HBSS
(Sigma-Aldrich). Cells were cultured for 2 h and washed
with HBSS to remove nonadherent cells. Adherent
monolayer cells were used as peritoneal macrophages.
Peritoneal macrophages were cultured with 10 ng/ml of
LPS (Escherichia coli serotype O55:B5), 1 µM of CpG
DNA, or 50 U/ml of IFN-γ (Genzyme, Cambridge, Mass-
achusetts, USA) plus LPS for 24 h. Concentrations of
TNF-α, IL-6, and IL-12p40 in the culture supernatants
were measured by ELISA according to the manufactur-
er’s instructions (Genzyme; Endogen Inc., Woburn,
Massachusetts, USA). Production of nitric oxide was
measured by the Greiss method using a NO2/NO3 Assay
Kit (DOJINDO, Kumamto, Japan).
Cytokine production by dendritic cells isolated from the large
intestine. The large intestine was removed aseptically.
After removal of colonic patches, the large intestine was
washed with RPMI-1640 on ice and stirred with 
RPMI-1640 containing 20 mM HEPES, 50 µg/ml of gen-
tamycin, 100 U/ml penicillin, 100 µg/ml streptomycin,
10% FCS, 5 mM EDTA for 60 min at 37°C. The tissues
were then digested with collagenase D (400 U/ml;
Boehringer Mannheim GmbH, Mannheim, Germany) in
RPMI-1640 containing 10% FCS for 30 min at 37°C and
further incubated in the presence of 5 mM EDTA for 5
min. The isolated cells were purified by centrifugation
through a 14.5% Accudenz gradient (Accurate Chemical
& Scientific Corp., Westbury, New York, USA). Cells were
further incubated with mouse CD11c microbeads (Mil-
tenyi Biotech, Bergisch Gladbach, Germany) and select-
ed on autoMACS separation columns (Miltenyi
Biotech). The purified dendritic cell fractions were more
than 95% CD11c+. These cells (105) were seeded on 
96-well plate and cultured in the presence or absence of
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100 ng/ml LPS for 24 h. Concentrations of IL-6 and 
IL-12 in the culture supernatants were analyzed by ELISA.
Cytokine production by splenic and colonic CD4+ T cells.
Spleens were removed aseptically and single-cell sus-
pensions were prepared. After the lysis of red blood
cells, cells were incubated with CD4 microbeads and
passed through a magnetized column (Miltenyi
Biotech). The purified T cell fractions were more than
95% CD4+ and more than 99% viable. Lymphocytes of
the lamina propria of the large intestine were isolated
as previously described (26). In brief, after excision of
colonic patches, the intestinal tissues were treated with
RPMI-1640 medium containing 1 mM EDTA for 20
min to remove the epithelial cells. The tissue was then
digested with 0.5 mg/ml of collagenase (400 U/ml;
Boehringer Mannheim GmbH) for 20 min at 37°C,
and this step was repeated two times. The collected
cells were washed and filtered through a nylon mesh.
CD4+ T cells were purified by the magnetic activated
cell-sorter system (Miltenyi Biotech) as described above.
CD4+ T cells were seeded on anti-CD3 Ab-coated (10
µg/ml in PBS) 96-well plates and cultured for 24 h.
Concentrations of IFN-γ in the culture supernatants
were analyzed by ELISA, according to the manufactur-
er’s directions (Genzyme).
Immunohistochemical analysis. Freshly obtained large
intestine was washed with PBS and frozen in Tissue-Tec
OCT compound (Sakura, Tokyo, Japan). Cryostat sec-
tions (6 µm) were fixed with cold acetone for 2 min and
dried and rehydrated with PBS. This step was followed
by blocking with PBS containing 20 mM HEPES, 10%
FBS, and 1 µg of Fc-blocking mAb (2.4G2; BD PharMin-
gen, San Diego, California, USA). Sections were stained
with FITC-conjugated anti-CD11c (HL3; BD PharMin-
gen) and phycoerythrin-conjugated (PE-conjugated)
anti-CD3ε (145-2C11; BD PharMingen) or PE-conju-
gated anti-CD11b (M1/70; BD PharMingen) mAbs for
2 h at room temperature. After washing with PBS, the
sections were analyzed by confocal microscopy (Bio-
Rad Laboratories Inc., Hercules, California, USA).
For IL-12 staining, tyramide signal amplification
method was adopted (TSA Biotin System; NEN Life
Science Products Inc., Boston, Massachusetts, USA).
Briefly, fixed cryostat sections were incubated with
biotin-conjugated IL-12 (p40/p70) mAb (C17.8; BD
PharMingen) for 1 h at room temperature, and washed
with washing buffer. Then, sections were stained with
streptavidin-HRP and biotinyl tyramide amplification
reagent. The sections were then incubated with strep-
tavidin-PE (BD PharMingen) and FITC-conjugated
anti-CD11c (HL3; BD PharMingen) or FITC-conjugat-
ed anti-CD11b (M1/70; BD PharMingen).
Northern blot analysis. Peritoneal macrophages were
treated with LPS for 2 h. Total RNA (10 µg) was extract-
ed using the TRIzol reagent (Invitrogen Corp., San
Diego, California, USA), electrophoresed, transferred
to a nylon membrane, and hybridized with cDNA
probe specific for SOCS3, IL-12p40, and β-actin.
Results
Stat1/Stat3 double-mutant mice developed chronic colitis. In
macrophages from myeloid-specific Stat3 mutant
mice, Stat1 is constitutively phosphorylated (20).
Stat1 has been shown to be essential for signaling
mediated by IFN-γ, which is known to be an important
cytokine for the priming of macrophage activity (21).
Therefore, we expected the constitutive activation of
Stat1 to confer abnormal activity of Stat3 mutant
macrophages. To address this issue, we generated mice
lacking both Stat1 and Stat3.
We performed a histopathological analysis on colons
of 8-week-old Stat1/Stat3 double-mutant mice (Figure
1, a–d). Control and Stat1 mutant mice did not show
any sign of pathological changes. On the contrary, the
colonic wall of Stat1/Stat3 double-mutant mice was
thickened, and the gland number was severely reduced,
as is the case in Stat3 mutant mice. These histopatho-
logical changes were observed as early as 5–6 weeks of
age in both Stat3 mutant and Stat1/Stat3 double-
mutant mice. Almost all regions of the colon were
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Figure 1 
IBDs in Stat1/Stat3 double-deficient mice. (a–d) Histologic examination of the colons of (a) control, (b) Stat1-deficient, (c) Stat3 mutant,
and (d) Stat1/Stat3 double-mutant mice at 8 weeks. H&E staining is shown. ×20. (e)The colitis scores shown for individual mice at 16 weeks
of age were total scores for individual sections as described in Methods. The severity of colitis in Stat1/Stat3 double-mutant mice was sig-
nificantly but only partially improved compared with Stat3 mutant mice (**P < 0.01). *P < 0.001 versus group of control mice.
affected in Stat3 mutant mice, but not in Stat1/Stat3
double-mutant mice at 24 weeks of age. In addition,
occurrence of ulcer and abscess was reduced in
Stat1/Stat3 double-mutant mice compared with Stat3
single-mutant mice. Thus, Stat1/Stat3 double-mutant
mice developed chronic enterocolitis, although the
severity of the colitis was diminished compared with
Stat3 mutant mice (Figure 1e).
We next analyzed production of IFN-γ by CD4+ T
cells isolated from spleens of Stat1/Stat3 double-
mutant and Stat3 mutant mice. Splenic T cells were
stimulated with PMA and ionomycin, and production
of IFN-γ and IL-4 by CD4+ cells was analyzed by intra-
cellular staining (Figure 2a). IFN-γ–producing CD4+ T
cells were significantly elevated in Stat3 single-mutant
mice. IFN-γ–producing cells were also increased in
Stat1/Stat3 double-mutant mice compared with that
of control mice, albeit the reduced numbers were in
comparison to Stat3 mutant T cells. We further puri-
fied CD4+ T cells from the intestinal lamina propria of
these mice and analyzed for IFN-γ production by ELISA
(Figure 2b). Intestinal CD4+ T cells from Stat1/Stat3
double-mutant mice produced increased level of IFN-γ
compared with control T cells. Thus, these findings
demonstrated that double mutation of Stat1 and Stat3
resulted in the increase of IFN-γ production by intes-
tinal CD4+ T cells in addition to splenic CD4+ T cells,
indicating an enhanced Th1 response.
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Figure 2 
Enhanced IFN-γ production in Stat1/Stat3 double-defi-
cient mice. (a) Spleen cells were stimulated with PMA
and ionomycin for 6 h, then stained for CD4, fixed, and
finally stained for IFN-γ and IL-4. Cells were analyzed on
FACS by gating on CD4+ population. The frequency of
cytokine-producing CD4+ cells is indicated as a per-
centage. (b) CD4+ T cells were purified from lamina
propria and stimulated with plate-bound anti-CD3 Ab.
The concentration of IFN-γ was measured by ELISA. (c)
Mice were intraperitoneally injected with thioglycollate,
and 3 days later peritoneal macrophages were isolated.
Macrophages were stimulated with 10 ng/ml LPS for 
24 h. Concentrations of TNF-α, IL-6, and IL-12p40 in
the culture supernatants were measured.
Figure 3
IBDs in TNF-α/Stat3 double-deficient mice. (a–d) Histologic examination of the colons of (a) control, (b) TNF-α–deficient, (c) Stat3
mutant, and (d) TNF-α/Stat3 double-mutant mice at 16 weeks. H&E staining is shown. ×20. (e) The colitis score of TNF-α/Stat3 dou-
ble-mutant mice at 16 weeks of age. TNF-α/Stat3 double-mutant mice developed severe chronic colitis, similar to Stat3 mutant mice.
*P < 0.001 versus group of control mice. (f) Mice were intraperitoneally injected with thioglycollate, and 3 days later peritoneal
macrophages were isolated. Macrophages were stimulated with 10 ng/ml LPS for 24 h. Concentrations of TNF-α, IL-6, and IL-12p40 in
the culture supernatants were measured. *Not detected.
Based on the result obtained by the analysis of CD4+
T cells, our next experiment was to characterize
macrophages. Although the analysis of the peritoneal
macrophages does not directly reflect involvement of
macrophages in intestinal inflammation, the inflam-
matory response can be estimated in cells of other ori-
gins, because the enhanced IFN-γ production was
observed not only in the intestinal T cells but also in
splenic T cells (Figure 2, a and b). Peritoneal
macrophages isolated from Stat1/Stat3 double-mutant
mice produced increased levels of TNF-α and IL-6 com-
pared with control or Stat1 mutant macrophages,
albeit lower compared with Stat3 mutant macrophages
(Figure 2c). IL-12p40 production from Stat1/Stat3
double-mutant macrophages was comparable to that
of Stat3 single-mutant macrophages. From these find-
ings we speculated that inflammatory cytokine syn-
thesis contributes to the development of chronic ente-
rocolitis in Stat1/Stat3 double-mutant mice.
TNF-α/Stat3 double-deficient mice suffered from severe chron-
ic enterocolitis. TNF-α is involved in a variety of inflamma-
tory processes, including the development of IBD (27).
Indeed, our previous and present studies demonstrated
that the level of TNF-αproduction was increased in Stat3
mutant mice (Figure 2c). Therefore, we next generated
mice lacking both Stat3 and TNF-α. Surprisingly, inflam-
matory changes including loss of gland, infiltration by
inflammatory cells, crypt abscess, and ulcers were
observed in the colon of TNF-α/Stat3 double-mutant
mice. The severity of disease was similar to that of Stat3
mutant mice (Figure 3, a–e). All of the TNF-α/Stat3 
double-mutant mice analyzed (six mice) developed severe
chronic enterocolitis, as did Stat3 mutant mice (Figure
3e). We next analyzed the LPS-induced inflammatory
cytokine production by peritoneal macrophages. 
TNF-α/Stat3 double-mutant macrophages produced
increased levels of IL-6 and IL-12 compared with
macrophages isolated from control mice (Figure 3f). In
particular, an extremely high level of IL-12p40 was pro-
duced by TNF-α/Stat3 double-mutant macrophages.
In the next set of experiments, production of IFN-γ by
CD4+ T cells isolated from spleen or intestinal lamina
propria of TNF-α/Stat3 double-mutant mice with coli-
tis was analyzed (Figure 4). CD4+ T cells isolated from
both spleen and intestinal lamina propria of TNF-α/
Stat3 double-mutant mice as well as Stat3 single-
mutant mice produced increased levels of IFN-γ. Thus,
TNF-α/Stat3 double-mutant mice also showed skewed
Th1 responses and developed chronic enterocolitis.
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Figure 4 
IFN-γ production by CD4+ T cells in spleen and lamina propria of
TNF-α/Stat3 double-mutant mice. CD4+ T cells were purified from
spleen and lamina propria (LPL), and stimulated with plate-bound
anti-CD3 Ab. The concentration of IFN-γ was measured by ELISA.
CD4+ T cells from TNF-α/Stat3 double-mutant mice produced sig-
nificantly increased levels of IFN-γ, similar to Stat3 mutant mice.
Figure 5
IL-12/Stat3 double-mutant mice showed no inflammatory change in the colon. (a) Peritoneal macrophages were stimulated with 10 ng/ml
LPS for 24 h. Concentrations of TNF-α, IL-6, and IL-12p40 in the culture supernatants were measured. *Not detected. (b–d) Histopathol-
ogy of the colons of (b) control, (c) IL-12–deficient, and (d) IL-12/Stat3 double-mutant mice at 16 weeks. H&E staining is shown. ×20. (e)
The colitis score of IL-12/Stat3 double-mutant mice at 16 weeks of age. None of the IL-12/Stat3 double-mutant mice showed any inflam-
matory change in the colon. *P < 0.001 between Stat3 mutant mice and control or IL-12/Stat3 double-mutant mice.
IL-12p40/Stat3 double-mutant mice did not develop chron-
ic enterocolitis. Based on the data obtained by the analy-
sis of Stat3 mutant mice inserted with additional gene
manipulation (Figures 1–3), it was obvious that elevat-
ed IL-12p40 synthesis by macrophages was consistent-
ly associated with the colitis development. Thus, it was
logical to generate IL-12p40/Stat3 double-mutant
mice. The analysis of the LPS-induced production of
inflammatory cytokines by peritoneal macrophages
revealed that IL-12p40/Stat3 double-mutant macro-
phages produced increased levels of TNF-α and IL-6,
which was comparable to those of Stat3 mutant
macrophages (Figure 5a). The double-mutant mice,
however, did not show any pathological sign of inflam-
mation in the colon (Figure 5, b–e). They also did not
develop colitis even at over 24 weeks of age, when Stat3
mutant mice suffered from severe chronic enterocoli-
tis (data not shown). These findings suggested a criti-
cal role of IL-12p40 for the development of colitis asso-
ciated with Stat3 deficiency.
To further support this view, we next analyzed the
production of IFN-γ by CD4+ T cells isolated from
spleen and colonic lamina propria of the double-
mutant mice (Figure 6). Colonic lamina propria CD4+
T cells of Stat3 mutant mice showed increased pro-
duction of IFN-γ; however, IFN-γ production by colonic
lamina propria CD4+ T cells of IL-12p40/Stat3 double-
mutant mice was reduced to the level of control mice.
Similar results were obtained when splenic CD4+ T cells
were examined (Figure 6). Taken together, these results
demonstrated that IL-12p40/Stat3 double-mutant
mice did not develop chronic enterocolitis with no
pathological IFN-γ producing Th1-type responses. We
thus suggest that IL-12–induced development of Th1
cells leads to the induction of severe chronic entero-
colitis in Stat3 mutant mice.
RAG2/Stat3 double-mutant mice did not develop chronic
enterocolitis. To further confirm the critical role of Th1
cells in the development of chronic enterocolitis in
Stat3 mutant mice, we next generated RAG2/Stat3
double-mutant mice, which lack T cells. Similar to
macrophages obtained from Stat3 mutant mice,
macrophages isolated from these double-mutant mice
produced increased levels of inflammatory cytokines
such as TNF-α, IL-6, and IL-12p40 (Figure 7a). RAG2/
Stat3 double-mutant mice, however, did not show 
any inflammatory change in the colon (Figure 7, b–e). 
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Figure 6
Normal production of IFN-γ by CD4+ T cells in spleen and lamina
propria of IL-12/Stat3 double-mutant mice. CD4+ T cells were puri-
fied from spleen and lamina propria (LPL) and stimulated with plate-
bound anti-CD3 Ab. The concentration of IFN-γ was measured by
ELISA. CD4+ T cells from IL-12/Stat3 double-mutant mice produced
normal levels of IFN-γ, unlike those from Stat3 mutant mice.
Figure 7
RAG2/Stat3 double-mutant mice showed no inflammatory change in the colon. (a) Peritoneal macrophages were stimulated with 10 ng/ml
LPS for 24 h. Concentrations of TNF-α, IL-6, and IL-12p40 in the culture supernatants were measured. (b–d) Histopathology of the colon
of (b) control, (c) RAG2-deficient, and (d) RAG2/Stat3 double-mutant mice at 16 weeks. H&E staining is shown. ×20. (e) The colitis score
of RAG2/Stat3 double-mutant mice at 16 weeks of age. None of the RAG2/Stat3 double-mutant mice showed any inflammatory change in
the colon. *P < 0.001 between Stat3 mutant mice and control or RAG2/Stat3 double-mutant mice.
None of the double-mutant mice analyzed developed
chronic enterocolitis even after 24 weeks of age (data
not shown). These findings further support our
hypothesis that myeloid cell-originated IL-12p40 medi-
ates the induction of Th1 cells contributing to the devel-
opment of chronic enterocolitis in Stat3 mutant mice.
TLR4 is involved in the pathogenesis of colitis in Stat3
mutant mice. In the absence of Stat3, macrophages were
abnormally activated and produced increased levels of
inflammatory cytokines such as IL-12p40 (Figures 2, 3,
5, 7). It was thus important to elucidate the triggering
mechanism for the increased production of IL-12p40
by Stat3 mutant macrophages. The biosynthesis of
inflammatory cytokines including IL-12p40 is known
to be induced by stimulation with bacterial compo-
nents such as LPS (28). Bacterial components have
recently been shown to be specifically recognized by the
pattern recognition family of TLRs (29). Among the
family members, TLR4 is an essential receptor for the
recognition of LPS (24, 30). Therefore, we finally gen-
erated TLR4/Stat3 double-mutant mice and analyzed
whether TLR4 is involved in the abnormal activation of
Stat3 mutant macrophages leading to the pathological
Th1 cell–mediated large intestinal inflammation. As
one might expect, LPS-induced production of inflam-
matory cytokines was not observed at all in macro-
phages isolated from TLR4/Stat3 double-mutant mice
(Figure 8a). We further analyzed the production of
IFN-γ by CD4+ T cells of TLR4/Stat3 double-mutant
mice (Figure 8b). The level of IFN-γ production by
CD4+ T cells isolated from TLR4/Stat3 double-mutant
mice was significantly decreased compared with Stat3
mutant mice. Thus, aberrant production of an inflam-
matory initiator cytokine, IL-12, by myeloid cells and
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Figure 8
Improved colitis in TLR4/Stat3 double-mutant mice. (a) Peritoneal macrophages were stimulated with 10 ng/ml LPS for 24 h. Concentra-
tions of TNF-α, IL-6, and IL-12p40 in the culture supernatants were measured. LPS-induced production of inflammatory cytokines was abol-
ished in TLR4/Stat3 double-mutant macrophages. *Not detected. (b) CD4+ T cells were purified from spleen and stimulated with plate-
bound anti-CD3 Ab. The concentration of IFN-γ was measured by ELISA. CD4+ T cells from TLR4/Stat3 double-mutant mice produced
reduced levels of IFN-γ compared with Stat3 mutant mice. (c–e) Histopathology of the colon of (c) control, (d) TLR4-deficient, and (e)
TLR4/Stat3 double-mutant mice at 16 weeks. H&E staining is shown. ×20. (f) The colitis score of TLR4/Stat3 double-mutant mice at 16
weeks of age. TLR4/Stat3 double-mutant mice showed no or moderate inflammatory changes in the colon. *P < 0.001 between Stat3 mutant
mice and control or TLR4/Stat3 double-mutant mice.
Figure 9
Impaired IL-10–induced expression of SOCS3 in Stat3 mutant
macrophages. (a) Peritoneal macrophages from control and Stat3
mutant mice were stimulated with 10 ng/ml IL-10 for 2 h and ana-
lyzed for SOCS3 mRNA expression by Northern blotting. (b) Peri-
toneal macrophages from control and Stat3 mutant mice were cul-
tured in the presence or absence of 10 ng/ml IL-10 for 24 h and then
stimulated with 10 ng/ml LPS for 2 h. Total RNA was extracted and
subjected to Northern blot analysis for IL-12p40 mRNA expression.
The same membrane was rehybridized with β-actin.
the Th1 cell development were improved in the absence
of TLR4. This notion was further supported by the
analysis of the histopathological change in the colon of
TLR4/Stat3 double-mutant mice (Figure 8, c–e). At 16
weeks of age, the inflammatory change was scarcely
detected in the colon of TLR4/Stat3 double-mutant
mice (Figure 8f). These findings clearly demonstrated
that removal of the initiation signal by LPS by TLR4
inhibited the abnormal activation of Stat3 mutant
macrophages, causing the development of colitis. It is
important to note, however, that some TLR4/Stat3
double-mutant mice (three of six mice analyzed)
showed some signs of inflammatory change in the
colon at around 24 weeks of age, although the severity
of affected region was reduced compared with Stat3
mutant mice (data not shown). Thus, in the absence of
TLR4, the onset of chronic enterocolitis was delayed,
and the severity and incidence of colitis was improved.
Taken together, these findings indicate that TLR4 is
involved in an initiation step of abnormal activation of
myeloid cells leading to the development of chronic
enterocolitis in Stat3 mutant mice.
Reduced expression of SOCS3 in Stat3 mutant macrophages.
Findings obtained by analysis of TLR4/Stat3 double-
mutant mice suggest that IL-10 exerts an anti-inflam-
matory activity by suppressing LPS responsiveness in
myeloid cells. Recently, genes induced by IL-10 stimula-
tion in macrophages have been identified and charac-
terized (31, 32). Among these gene products, SOCS3 has
been shown to inhibit the LPS-induced expression of
TNF-α, IL-6, and iNOS in macrophages (32). We there-
fore analyzed IL-10–induced mRNA expression of
SOCS3 in peritoneal macrophages of Stat3 mutant mice
(Figure 9a). In control mice, IL-10 stimulation resulted
in robust expression of SOCS3 mRNA. IL-10–induced
SOCS3 expression, however, was not observed in Stat3
mutant mice. Accordingly, IL-10–mediated suppression
of LPS-induced IL-12p40 expression, which was ob-
served in control macrophages, was abrogated in Stat3
mutant macrophages (Figure 9b). These findings indi-
cate that IL-10–induced activation of Stat3 is critical to
suppression of LPS-induced IL-12p40 production in
macrophages, possibly through expression of anti-
inflammatory molecules such as SOCS3.
Dendritic cells and macrophages in the large intestine were
increased in number and showed enhanced IL-12 production in
Stat3 mutant mice. The inflammatory change observed in
Stat3 mutant mice was restricted to the large intestine.
Furthermore, our present findings described above pro-
vided strong evidence that aberrant production of 
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Figure 10
Macrophages and dendritic cells in the large intestine
were increased in number and produced IL-12p40 in
Stat3 mutant mice with colitis. (a–f) Immunohisto-
chemistry of the colon of (a, c, e) control and (b, d,
f) Stat3 mutant mice at 16 weeks. The colon sections
were stained with anti-CD11c Ab (green) (a, b, e, f),
anti-CD11b Ab (red) (c and d), and anti-CD3 Ab
(red) (e and f). Bar: 10 µm. (g) CD11c-positive den-
dritic cells in the large intestine were stimulated with
100 ng/ml LPS for 24 h. Concentrations of IL-6 and
IL-12p40 in the culture supernatants were measured.
*Not detected. (h) Immunohistochemistry of the
colon of Stat3 mutant mice. The colon sections were
stained with anti–IL-12p40 Ab (red) and anti-CD11c
Ab (green) oranti-CD11b Ab (green). Bar: 10 µm.
IL-12p40 by Stat3 mutant myeloid cells directly con-
tribute to the development of colonic inflammation by
the generation of pathological Th1 cell environment.
Therefore, we speculate that myeloid cells residing in
the large intestine play important roles in the develop-
ment of colitis in the mutant mice. To directly examine
the involvement of mucosal dendritic cells and
macrophages in the pathogenesis, immunohistochem-
ical study was carried out in the large intestine of Stat3
mutant mice with colitis. The number of accumulated
CD11c+ dendritic cells and CD11b+ macrophages was
significantly increased in the large intestine of Stat3
mutant mice compared with those of control mice (Fig-
ure 10, a–d). Dendritic cells were mainly observed in the
epithelium region and some in the lamina propria and
the submucosal regions (Figure 10, a and b). CD11b+
macrophages were also observed in the epithelium and
lamina propria region of the large intestine. Colocaliza-
tion of CD3+ T cells with CD11c+ dendritic cells was rare
in the lamina propria of control mice (Figure 10e). Large
numbers of CD3+ T cells, however, were located adjacent
to CD11c+ dendritic cells in Stat3 mutant mice (Figure
10f). These findings suggest a possibility that localized
direct interaction between dendritic cells and T cells at
the mucosal surface may initiate the creation of IL-12–
mediated pathological Th1 environment leading to the
development of colitis.
To examine this possibility, we next purified CD11c+
dendritic cells from the large intestine of Stat3 mutant
mice for the analysis of cytokine production (Figure
10g). Dendritic cells isolated from control mice did not
show any production of IL-12p40 upon stimulation
with LPS. In contrast, dendritic cells obtained from
Stat3 mutant mice showed marked production of 
IL-12p40 without stimulation (Figure 10g). The level
of IL-12p40 production was further enhanced when
cultured with LPS. These findings clearly demonstrat-
ed that Stat3 mutant dendritic cells are committed for
the pathological production of IL-12p40. In addition
to the elevated IL-12p40 production, Stat3 mutant
dendritic cells produced increased level of IL-6 com-
pared with the cells isolated from control mice,
although mucosal dendritic cells did not produce any
detectable level of TNF-α in both control and Stat3
mutant mice (Figure 10g, data not shown).
Finally, we examined expression of IL-12 in intes-
tinal macrophages and dendritic cells by immunohis-
tochemistry. In control mice, CD11b+ macrophages
and CD11c+ dendritic cells scarcely expressed IL-12
(data not shown). In contrast, both CD11b+ macro-
phages and CD11c+ dendritic cells expressed IL-12 in
the large intestine of Stat3 mutant mice (Figure 10h).
Thus, macrophages and dendritic cells residing in the
large intestine were increased in number, showed
enhanced production of IL-12, and many of the den-
dritic cells colocalized with CD3+ T cells. These find-
ings suggest that macrophages and dendritic cells
residing in the large intestine are involved in the
development of chronic enterocolitis by instruction
of Th1 cell development through IL-12p40 produc-
tion in Stat3 mutant mice.
Discussion
In the present study, we analyzed the molecular mech-
anism by which abnormally activated Stat3 mutant
myeloid cells induce development of chronic entero-
colitis in vivo using several gene-manipulated mice
where additional gene deletion were introduced into
Stat3 mutant mice. Previous study indicated that IL-10
is an important cytokine that prevents the develop-
ment of chronic enterocolitis (2). CD4+ T cells of 
IL-10–deficient mice showed the Th1 phenotype by
producing an increased level of IFN-γ (8), and the adop-
tive transfer of these CD4+ T cells into immunocom-
promised mice resulted in the induction of colitis (9).
Treatment with neutralizing anti–IL-12 Ab prevented
the colitis development in young IL-10–deficient mice
(10). These lines of evidence indicate that the entero-
colitis observed in IL-10–deficient mice is associated
with the increased Th1-type responses. It remains
unclear, however, how the IL-10 deficiency led to the
development of chronic enterocolitis in vivo. This
study demonstrated that defective IL-10 signaling
caused by the absence of Stat3 in myeloid cells resulted
in the Th1-mediated enterocolitis in mice. Further-
more, aberrant production of IL-12p40 by Stat3
mutant myeloid cells is a key pathological element for
the development of Th1-dependent enterocolitis. In
the absence of IL-10 or IL-10 signaling represented by
IL-10 knockout or Stat3 deficiency, respectively,
myeloid cells including macrophages and dendritic
cells were activated and produced increased levels of
inflammatory cytokines. Among these inflammatory
cytokines, IL-12 instructs the development of Th1 cells,
which confer the pathogenesis of enterocolitis. IL-12p40
associates with p35 to form bioactive IL-12 and addi-
tionally engages p19 to form IL-23, which has several
overlapping activities with IL-12 (33). Since IL-12p40–
deficient mice, which lack both IL-12 and IL-23, were
used in this study, we cannot exclude a possible patho-
logical role of IL-23 in addition to IL-12 for the devel-
opment of Th1-dependent diseases.
IL-10 has been shown to instruct the development of
regulatory T cells, which have a capacity to prevent the
development of chronic enterocolitis induced by Th1-
type responses (12, 13). In the Stat3 mutant mice, LPS-
induced IL-10 production was significantly increased
(20). Furthermore, a population of CD4+CD25+ regula-
tory T cells in the spleen of the Stat3 mutant mice was
increased compared with control mice (14–17% versus
5–6%; our unpublished data). These regulatory T cells
had a low capacity to proliferate and furthermore had
an ability to inhibit proliferation of CD4+ T cells, indi-
cating that the cells of Stat3 mutant mice have a normal
inhibitory activity as regulatory T cells (our unpub-
lished data). In the Stat3 mutant mice, IL-10–mediated
signaling was not affected in T cells, because Stat3 pro-
tein was normally observed in the T cell population (20).
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IL-10 has been shown to induce the development of
regulatory T cells (34). Therefore, overproduction of 
IL-10 may account for the increased number of regula-
tory T cells in the Stat3 mutant mice. Although regu-
latory T cells have been well established to inhibit the
development of colitis (12, 13), our present and ongo-
ing studies suggest that colitis is developed in the Stat3
mutant mice, despite regulatory T cells increasingly
present. These findings imply that even in the presence
of IL-10 and regulatory T cells, exaggerated Th1
responses due to the aberrant activation of myeloid
cells lead to the development of chronic inflammation
in the Stat3 mutant mice.
In the Stat3 mutant mice, there is a possibility that
not only Th1 cells but also inflammatory cytokines
contribute to the pathogenesis of enterocolitis. In par-
ticular, TNF-α is known to be a potent inducer of sev-
eral inflammatory diseases (27). Indeed, anti–TNF-α
Ab has been used successfully in a clinical setting for
the treatment of IBD such as Crohn disease (35). Mice
that overproduced TNF-α due to a deletion of adeno-
sine-uracil–rich elements from the 3′-untranslated
region of the TNF-α gene developed Crohn-like colitis
(36). In this model, colitis was not induced in the
RAG1–/– background, indicating that lymphocytes are
critical mediators for the development of colitis. Addi-
tionally, Crohn disease patients who responded to
anti–TNF-αAb showed downregulation of TNF-α, and
subsequently IFN-γ, indicating that increased Th1
responses evoked by TNF-α in the mucosa are critical
for pathogenesis (37, 38). TNF-α/Stat3 double-mutant
mice developed severe chronic enterocolitis (Figure 3).
Similarly, treatment with anti–TNF-α Ab in young 
IL-10–deficient mice did not prevent colitis (39).
Although a report showed that colitis was improved in
TNF-α/IL-10 double-deficient mice, some of these
mice developed severe colitis (40). Thus, TNF-α does
not seem to be directly involved in the pathogenesis of
colitis in Stat3 mutant and IL-10–deficient mice. Fur-
thermore, reconstitution of RAG2-deficient mice with
CD4+ T cells from Stat3 mutant mice induced the
development of chronic enterocolitis (our unpublished
data). Therefore, we conclude that Th1 cells are the
most important inducers of chronic enterocolitis in
Stat3 mutant mice. This model clearly demonstrated
that abnormal activity by myeloid cells is a first trigger
to induce Th1-dependent inflammatory diseases. In
TNF-α/Stat3 double-mutant mice, IL-12p40 produc-
tion was significantly increased even when compared
with Stat3 single-mutant mice (Figure 3f). TNF-α has
been shown to be one of important cytokines that are
involved in prevention of microbial infection (41, 42).
In the apical surface of the large intestine of TNF-α/
Stat3 double-mutant mice, many of rod-type bacteria
can be easily detected in comparison with Stat3 single-
mutant and control mice (our unpublished data).
Therefore, although precise mechanism by which 
IL-12p40 production was increased is unclear, we could
provide a speculation that the deficiency of TNF-αmay
lead to the impairment of mucosal innate immunity
for the control of intestinal microflola, including the
invasion of pathogen via the epithelium. Thus, several
intestinal pathogens or commensal bacteria may easi-
ly invade into the intestinal tissues, which may result in
an increased chronic stimulation of myeloid cell lead-
ing to the overproduction of IL-12p40.
Although Stat1 was constitutively activated in Stat3
mutant macrophages by unknown mechanisms (20),
the insertion of Stat1 deficiency only partially improved
the severity of colitis in Stat3 mutant mice (Figure 1).
Stat1 plays an essential role in the signaling pathway of
IFN-γ, which is an important mediator of Th1 responses
(21). Therefore, Th1-mediated responses should be
impaired in Stat1/Stat3 double-deficient mice, and thus
lack of the disease development was expected. Our find-
ings, however, demonstrated that the insertion of Stat1
deficiency into Stat3 mutant mice did not prevent the
development of chronic enterocolitis. For the explana-
tion of this unexpected result, we propose two possibil-
ities. One is as follows: several recent reports demon-
strated the presence of a Stat1-independent pathway in
IFN-γ signaling (43–46). In Stat1/Stat3 double-deficient
mice, IFN-γ production from CD4+ T cells was signifi-
cantly increased, indicating that these mice exhibited
skewed Th1 responses even in the absence of Stat1 (Fig-
ure 2, b and c). Therefore, IFN-γ–mediated Stat1-inde-
pendent signaling may confer the induction of chronic
colitis in these double-mutant mice. Alternatively, the
adoptive transfer of CD4+ T cells isolated from IFN-γ–
deficient mice has been shown to induce Th1-mediated
colitis in immunocompromised mice (47). Treatment
with anti–IFN-γAb was less effective than anti–IL-12 Ab
in preventing the colitis development in IL-10–deficient
mice (8, 10). These results indicate that destructive cell-
mediated immune responses can be provided by Th1
cells without the involvement of IFN-γ production for
the development of colitis.
In this study, a key initiator molecule that can trigger
an abnormal activation of myeloid cells in the absence of
IL-10 signaling was also demonstrated. A family of TLRs
has recently been identified as pattern recognition mol-
ecules of microbial components, which leads to the acti-
vation of innate immune cells such as macrophages and
dendritic cells (29). Among these TLRs, TLR4 is essential
for the recognition of LPS. In the absence of TLR4,
macrophages from Stat3 mutant mice did not produce
any inflammatory cytokines in response to LPS, and the
incidence and severity of colitis were greatly improved
(Figure 8). These findings indicate that TLR4 is a key ini-
tiating molecule, which triggers an abnormal activation
of myeloid cells leading to the development of chronic
enterocolitis. Previous studies showed that various gene-
manipulated mice developing colitis in a specific
pathogen-free environment do not show any inflamma-
tory change in a germ-free environment and that treat-
ment of young IL-10–deficient mice with antibiotics pre-
vented the development of colitis (48, 49). These
findings indicate that one contributing factor for the
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triggering mucosal inflammation could be “intestinal
microflora,” commensal microorganisms resident on
the mucosal surface (7). Therefore, we propose the fol-
lowing hypothesis: TLRs expressed on myeloid cells rec-
ognize microbial components of the mucosal microflo-
ra and activate myeloid cells to produce inflammatory
cytokines including IL-10, IL-12, and TNF-α. In normal
conditions, IL-10, which is produced by myeloid cells
and regulatory T cells, suppresses the activity of myeloid
cells. In the absence of IL-10 signaling, however, myeloid
cells are abnormally activated through TLRs and pro-
duce increased levels of inflammatory cytokines. Among
these, IL-12 induces the development of colitis through
the generation of aberrant Th1 cells.
Some of TLR4/Stat3 double-mutant mice developed
colitis at old age, indicating that other TLRs may be
involved in the initiation of pathogenesis. TLR9, which
induces potent Th1 responses through recognition of
CpG DNA in vivo, is one such candidate (50). CpG
DNA induced increased production of inflammatory
cytokines, including IL-12p40, in TLR4/Stat3 double-
mutant macrophages (our unpublished data). There-
fore, we speculate that constitutive exposure of micro-
bial components such as CpG DNA may eventually
prime myeloid cells to produce increased level of
inflammatory cytokines in the TLR4/Stat3 double-
mutant mice. Even in the absence of LPS signaling, the
abnormal activity of myeloid cells may eventually lead
to the induction of pathological Th1 responses in the
double-mutant mice. It should be noted, however, that
the level of the CpG DNA/TLR9–mediated IL-12p40
production by the double-mutant macrophages was
lower when compared with the Stat3 mutant
macrophages, which may explain one of the causes for
the improvement of colitis in the double-mutant mice
(our unpublished data). In addition to TLR9, TLR5,
which has been shown to be expressed on the basolat-
eral side of intestinal epithelia and recognize bacterial
flagellin, may also be involved in the initiation of
inflammation cascade in the large intestine (51, 52).
One of the other interesting findings of the present
study is the demonstration of the accumulation of den-
dritic cells and macrophages in the disease site of Stat3
mutant mice (Figure 10). These myeloid lineages of
mucosal APCs produced increased level of inflammato-
ry cytokines such as IL-12p40 and IL-6. It should also
be noted that colocalization of mucosal dendritic cells
and CD3+ T cells was directly demonstrated in the large
intestine of Stat3 mutant mice with colitis. Further-
more, intestinal dendritic cells have been shown to
extend their dendron to the lumen side of the intestine
(53). Thus, the direct communication between the den-
dritic cell/T cell clusters and outside environments,
including the commensal microflora, may occur
through TLRs and microbial components, respectively,
at the intestinal mucosa, which instructs the initiation
of large-intestinal inflammation in Stat3 mutant mice.
Finally, we demonstrated that IL-10–induced expres-
sion of SOCS3 is dependent on Stat3 in macrophages
(Figure 9, a–f). SOCS3 has been shown to inhibit the
LPS-induced expression of TNF-α, IL-6, and iNOS in
macrophages (32). Our present results show that the
severe reduction in the expression of SOCS3 well corre-
lates with the impaired IL-10–mediated suppression of
the LPS-induced IL-12p40 expression in Stat3 mutant
macrophages (Figure 9). Interestingly, expression of 
IL-12p40 mRNA induced by 2-h LPS stimulation was
comparable between control and Stat3 mutant macro-
phages (Figure 9b). IL-12p40 protein production during
24-h stimulation, however, was significantly increased in
Stat3 mutant mice (Figures 2, 3, 5, 7). These findings
may indicate that the initial LPS response was equivalent
between control and Stat3 mutant macrophages, but
after several hours of LPS stimulation, the difference
may arise for the induction of IL-10–inducible genes
associated with suppressor activity. Our findings suggest
that one candidate would be IL-10–mediated expression
of SOCS3 that suppresses macrophage activity. One
must emphasize, however, that several other genes are
also induced in response to IL-10 in macrophages (ref.
31 and our unpublished data). Therefore, there is a pos-
sibility that an additional gene product other than
SOCS3 may also be responsible for the IL-10–mediated
suppression of macrophages. Precise analysis of the
mechanism by which IL-10 suppresses activity of
myeloid cells, especially in response to LPS stimulation,
would be an interesting issue, which needs to be eluci-
dated in the future.
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